Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study.
暂无分享,去创建一个
P. Chevallier | D. Blaise | M. Béné | L. Fornecker | N. Ifrah | P. Cornillet‐Lefèbvre | I. Luquet | D. Bouscary | J. Harousseau | O. Blanchet | C. Berthou | A. Pigneux | M. Hunault | J. Cahn | B. Lioure | T. Lamy | J. Cornillon | M. Delain | Edouard Randriamalala | F. Larosa | N. Fegueux | M. Ojeda-Uribe | A. Huynh | M. Carré | B. Witz
[1] Takuhiro Yamaguchi,et al. Comparison of allogeneic hematopoietic cell transplantation and chemotherapy in elderly patients with non-M3 acute myelogenous leukemia in first complete remission. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[2] M. Tallman,et al. Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns. , 2011, Blood.
[3] H. Ai,et al. Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients. , 2011, Blood.
[4] J. Ritz,et al. Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[5] M. Bernard,et al. Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial , 2010, Leukemia.
[6] Bob Löwenberg,et al. Review Articles (434 articles) , 2008 .
[7] A. Nagler,et al. Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up , 2010, Leukemia.
[8] L. Shaffer,et al. Nomenclature Evolution: Changes in the ISCN from the 2005 to the 2009 Edition , 2010, Cytogenetic and Genome Research.
[9] Hisashi Sakamaki,et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. , 2009, JAMA.
[10] D. Blaise,et al. Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a ‘donor’ versus ‘no donor’ comparison , 2009, Leukemia.
[11] J. Rowe. Optimal induction and post-remission therapy for AML in first remission. , 2009, Hematology. American Society of Hematology. Education Program.
[12] M. Mohty. [Allogeneic hematopoietic stem cell transplantation]. , 2008, La Revue du praticien.
[13] F. Aversa,et al. Competing risk analysis using R: an easy guide for clinicians , 2007, Bone Marrow Transplantation.
[14] D. Blaise,et al. Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia. , 2007, Haematologica.
[15] E. Estey,et al. Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). , 2007, Blood.
[16] D. Blaise,et al. Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first‐line treatment , 2005, Cancer.
[17] H. Hara,et al. Allogeneic Hematopoietic Stem Cell Transplantation , 2003, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[18] H. Deeg,et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. , 2001, Blood.
[19] M. Labopin,et al. Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years , 1997, Leukemia.